TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
GNLX

Genelux Corporation

Healthcare · Biotechnology

2.50$ +2.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GNLX
Line item 2019 2020 2021 2022 2023 2024 2025
– +326.9% -42.0% -31.9% +404.3% +24.5% -45.2%
– +1,982.9% -49.3% -67.5% +1,179.2% +30.3% -52.0%
– +2,570.6% -60.4% -91.2% +2,272.3% -9.1% -37.7%
– +2,570.6% -60.4% -91.2% +5,741.6% +33.2% -52.8%
– -7.5% -9.8% – – – –
– +30.5% +12.5% +0.2% -79.6% +0.3% -11.4%
– -1.6% +55.1% +40.7% -79.3% +5.3% -9.8%
– -15.6% +68.6% +154.2% -96.1% -49.6% +29.8%
– -74.5% +381.3% +51.8% -44.1% +47.2% -21.8%
– – -16.9% -52.7% – – –
– – – – – +34.9% -56.1%
– – – – – – –
– +0.0% +0.0% +4.0% -0.5% +28.7% +18.2%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?